Edgar
Lookup
Industries
Insiders
Forms
Rankings
Articles
Home
/
Viking Therapeutics, Inc.
/
Filings
/
ARS
ARS
ARS
Company
Viking Therapeutics, Inc.
Filed
April 8, 2025
Period of Report
December 31, 2024
Accession Number
0000950170-25-052204
View Document ↗
View on SEC.gov ↗